Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05222802
Title A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Erasca, Inc.
Indications

glioblastoma

Therapies

ERAS-801

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST